News from NORD

Alport Syndrome Foundation Announces Research Funding

Publish date: February 17, 2017

 

The Alport Syndrome Foundation has announced the availability of funding for research to find novel treatments to prevent kidney failure and hearing loss in all patients with Alport syndrome. Two $100,000 projects are anticipated. Proposals are due March 20, 2017.

Recommended Reading

PERSIST-2 might allay some concerns about pacritinib in myelofibrosis
MDedge Hematology and Oncology
VIDEO: Despite toxicities, ibrutinib is beneficial for treatment-resistant graft-vs.-host disease
MDedge Hematology and Oncology
AWaRDS Study Examines Services for Adults With Rare Disorders
MDedge Hematology and Oncology
Nivolumab safe, effective for salvage in advanced gastric cancer
MDedge Hematology and Oncology
NORD Seeks Input Regarding Patient Protections and ACA
MDedge Hematology and Oncology
Rare Disease Day 2017 Will Highlight Research Theme
MDedge Hematology and Oncology
NORD to Partner Again With Hole in the Wall Gang Camp
MDedge Hematology and Oncology
Apply Now to Join NORD’s Charity Marathon Team
MDedge Hematology and Oncology
CORD Offers Consensus Framework for Ethical Collaboration
MDedge Hematology and Oncology
NORD Publishes Report on Spontaneous Intracranial Hypotension (SIH)
MDedge Hematology and Oncology